The Impact of an Incidental Dose on Axillary Tumor Control and Toxicity in Localized Breast Cancer: A Retrospective Analysis

Purpose: The dosimetric analysis of the incidental axillary dose delivered to axillary lymph node levels I–III by different techniques of whole breast irradiation and the analysis of prognostic factors of axillary recurrence of breast cancer. Methods: We perform a retrospective analysis that include...

Full description

Saved in:
Bibliographic Details
Published in:Cancers Vol. 14; no. 3; p. 807
Main Authors: Schmitt, Martin, Chambrelant, Isabelle, Hong Chheang, Parigna, Pflumio, Carole, Hild, Carole, Petit, Thierry, Noël, Georges
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 04.02.2022
MDPI
Subjects:
ISSN:2072-6694, 2072-6694
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Purpose: The dosimetric analysis of the incidental axillary dose delivered to axillary lymph node levels I–III by different techniques of whole breast irradiation and the analysis of prognostic factors of axillary recurrence of breast cancer. Methods: We perform a retrospective analysis that includes 171 patients with localized breast carcinoma irradiated at Centre Paul Strauss. To be included in the study, patients had to have a histological confirmation of breast cancer diagnosis, surgical treatment without axillary lymph node dissection (ALND), whole breast irradiation without axillary irradiation by a specific field, and a treatment plan available. Results: Three patients had lymph node recurrence. There was no significant correlation between the maximal or mean dose delivered at the three axillary levels and the risk of axillary lymph node recurrence. There was no significant correlation between the irradiation technique and the risk of axillary lymph node recurrence. Two patients, both in the HT group, had lymphoedema. There was significantly more lymphoedema in the HT group than in the ST and IMRT groups (p < 0.048). The mean dose in level II was significantly higher in the group of patients with lymphoedema (3.45 Gy (1.08; 9.62) vs. 23.4 Gy (23.1; 23.6)) (p < 0.02). Conclusion: The irradiation technique has an influence on the incidental dose delivered to the axillary area, but has no influence on the risk of axillary recurrence. The risk of lymphoedema could be related to the use of HT and the mean dose delivered at level II.
AbstractList The dosimetric analysis of the incidental axillary dose delivered to axillary lymph node levels I-III by different techniques of whole breast irradiation and the analysis of prognostic factors of axillary recurrence of breast cancer.PURPOSEThe dosimetric analysis of the incidental axillary dose delivered to axillary lymph node levels I-III by different techniques of whole breast irradiation and the analysis of prognostic factors of axillary recurrence of breast cancer.We perform a retrospective analysis that includes 171 patients with localized breast carcinoma irradiated at Centre Paul Strauss. To be included in the study, patients had to have a histological confirmation of breast cancer diagnosis, surgical treatment without axillary lymph node dissection (ALND), whole breast irradiation without axillary irradiation by a specific field, and a treatment plan available.METHODSWe perform a retrospective analysis that includes 171 patients with localized breast carcinoma irradiated at Centre Paul Strauss. To be included in the study, patients had to have a histological confirmation of breast cancer diagnosis, surgical treatment without axillary lymph node dissection (ALND), whole breast irradiation without axillary irradiation by a specific field, and a treatment plan available.Three patients had lymph node recurrence. There was no significant correlation between the maximal or mean dose delivered at the three axillary levels and the risk of axillary lymph node recurrence. There was no significant correlation between the irradiation technique and the risk of axillary lymph node recurrence. Two patients, both in the HT group, had lymphoedema. There was significantly more lymphoedema in the HT group than in the ST and IMRT groups (p < 0.048). The mean dose in level II was significantly higher in the group of patients with lymphoedema (3.45 Gy (1.08; 9.62) vs. 23.4 Gy (23.1; 23.6)) (p < 0.02).RESULTSThree patients had lymph node recurrence. There was no significant correlation between the maximal or mean dose delivered at the three axillary levels and the risk of axillary lymph node recurrence. There was no significant correlation between the irradiation technique and the risk of axillary lymph node recurrence. Two patients, both in the HT group, had lymphoedema. There was significantly more lymphoedema in the HT group than in the ST and IMRT groups (p < 0.048). The mean dose in level II was significantly higher in the group of patients with lymphoedema (3.45 Gy (1.08; 9.62) vs. 23.4 Gy (23.1; 23.6)) (p < 0.02).The irradiation technique has an influence on the incidental dose delivered to the axillary area, but has no influence on the risk of axillary recurrence. The risk of lymphoedema could be related to the use of HT and the mean dose delivered at level II.CONCLUSIONThe irradiation technique has an influence on the incidental dose delivered to the axillary area, but has no influence on the risk of axillary recurrence. The risk of lymphoedema could be related to the use of HT and the mean dose delivered at level II.
The dosimetric analysis of the incidental axillary dose delivered to axillary lymph node levels I-III by different techniques of whole breast irradiation and the analysis of prognostic factors of axillary recurrence of breast cancer. We perform a retrospective analysis that includes 171 patients with localized breast carcinoma irradiated at Centre Paul Strauss. To be included in the study, patients had to have a histological confirmation of breast cancer diagnosis, surgical treatment without axillary lymph node dissection (ALND), whole breast irradiation without axillary irradiation by a specific field, and a treatment plan available. Three patients had lymph node recurrence. There was no significant correlation between the maximal or mean dose delivered at the three axillary levels and the risk of axillary lymph node recurrence. There was no significant correlation between the irradiation technique and the risk of axillary lymph node recurrence. Two patients, both in the HT group, had lymphoedema. There was significantly more lymphoedema in the HT group than in the ST and IMRT groups ( < 0.048). The mean dose in level II was significantly higher in the group of patients with lymphoedema (3.45 Gy (1.08; 9.62) vs. 23.4 Gy (23.1; 23.6)) ( < 0.02). The irradiation technique has an influence on the incidental dose delivered to the axillary area, but has no influence on the risk of axillary recurrence. The risk of lymphoedema could be related to the use of HT and the mean dose delivered at level II.
Purpose: The dosimetric analysis of the incidental axillary dose delivered to axillary lymph node levels I–III by different techniques of whole breast irradiation and the analysis of prognostic factors of axillary recurrence of breast cancer. Methods: We perform a retrospective analysis that includes 171 patients with localized breast carcinoma irradiated at Centre Paul Strauss. To be included in the study, patients had to have a histological confirmation of breast cancer diagnosis, surgical treatment without axillary lymph node dissection (ALND), whole breast irradiation without axillary irradiation by a specific field, and a treatment plan available. Results: Three patients had lymph node recurrence. There was no significant correlation between the maximal or mean dose delivered at the three axillary levels and the risk of axillary lymph node recurrence. There was no significant correlation between the irradiation technique and the risk of axillary lymph node recurrence. Two patients, both in the HT group, had lymphoedema. There was significantly more lymphoedema in the HT group than in the ST and IMRT groups (p < 0.048). The mean dose in level II was significantly higher in the group of patients with lymphoedema (3.45 Gy (1.08; 9.62) vs. 23.4 Gy (23.1; 23.6)) (p < 0.02). Conclusion: The irradiation technique has an influence on the incidental dose delivered to the axillary area, but has no influence on the risk of axillary recurrence. The risk of lymphoedema could be related to the use of HT and the mean dose delivered at level II.
Simple SummaryThe incidental axillary dose varies according to the whole breast irradiation technique. However, this dose has not been shown to be a prognostic factor for locoregional recurrence. The objectives of our retrospective study are to dosimetrically evaluate the incidental axillary dose according to the different irradiation techniques and the risk factors of axillary recurrence. We confirmed that the irradiation technique has an influence on the incidental dose delivered to the axillary area, but has no influence on the risk of axillary recurrence. The risk of lymphoedema could be related to the use of high tangential beams and the mean dose delivered at level II.AbstractPurpose: The dosimetric analysis of the incidental axillary dose delivered to axillary lymph node levels I–III by different techniques of whole breast irradiation and the analysis of prognostic factors of axillary recurrence of breast cancer. Methods: We perform a retrospective analysis that includes 171 patients with localized breast carcinoma irradiated at Centre Paul Strauss. To be included in the study, patients had to have a histological confirmation of breast cancer diagnosis, surgical treatment without axillary lymph node dissection (ALND), whole breast irradiation without axillary irradiation by a specific field, and a treatment plan available. Results: Three patients had lymph node recurrence. There was no significant correlation between the maximal or mean dose delivered at the three axillary levels and the risk of axillary lymph node recurrence. There was no significant correlation between the irradiation technique and the risk of axillary lymph node recurrence. Two patients, both in the HT group, had lymphoedema. There was significantly more lymphoedema in the HT group than in the ST and IMRT groups (p < 0.048). The mean dose in level II was significantly higher in the group of patients with lymphoedema (3.45 Gy (1.08; 9.62) vs. 23.4 Gy (23.1; 23.6)) (p < 0.02). Conclusion: The irradiation technique has an influence on the incidental dose delivered to the axillary area, but has no influence on the risk of axillary recurrence. The risk of lymphoedema could be related to the use of HT and the mean dose delivered at level II.
Author Pflumio, Carole
Noël, Georges
Hild, Carole
Schmitt, Martin
Chambrelant, Isabelle
Hong Chheang, Parigna
Petit, Thierry
AuthorAffiliation 2 Radiotherapy Department, Khmer Soviet Friendship Hospital, Yuthapol Khemarak Phoumin Blvd, Phnom Penh 12306, Cambodia; p.hongchheang@icans.eu
1 Radiotherapy Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France; ma.schmitt@icans.eu (M.S.); i.chambrelant@icans.eu (I.C.)
3 Medical Oncology Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France; c.pflumio@icans.eu (C.P.); t.petit@icans.eu (T.P.)
4 Breast Surgery Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France; c.hild@icans.eu
AuthorAffiliation_xml – name: 1 Radiotherapy Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France; ma.schmitt@icans.eu (M.S.); i.chambrelant@icans.eu (I.C.)
– name: 3 Medical Oncology Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France; c.pflumio@icans.eu (C.P.); t.petit@icans.eu (T.P.)
– name: 4 Breast Surgery Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France; c.hild@icans.eu
– name: 2 Radiotherapy Department, Khmer Soviet Friendship Hospital, Yuthapol Khemarak Phoumin Blvd, Phnom Penh 12306, Cambodia; p.hongchheang@icans.eu
Author_xml – sequence: 1
  givenname: Martin
  orcidid: 0000-0002-3969-6610
  surname: Schmitt
  fullname: Schmitt, Martin
– sequence: 2
  givenname: Isabelle
  orcidid: 0000-0002-8102-771X
  surname: Chambrelant
  fullname: Chambrelant, Isabelle
– sequence: 3
  givenname: Parigna
  surname: Hong Chheang
  fullname: Hong Chheang, Parigna
– sequence: 4
  givenname: Carole
  surname: Pflumio
  fullname: Pflumio, Carole
– sequence: 5
  givenname: Carole
  surname: Hild
  fullname: Hild, Carole
– sequence: 6
  givenname: Thierry
  surname: Petit
  fullname: Petit, Thierry
– sequence: 7
  givenname: Georges
  orcidid: 0000-0003-4952-5572
  surname: Noël
  fullname: Noël, Georges
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35159074$$D View this record in MEDLINE/PubMed
BookMark eNp1kdtrFDEUxoNU7MU--yYBX3xZm8llMuODsN2qXVgQZH0OZzIZm5JJ1iRTutI_vumVumDykAP5fR_nnO8Q7fngDULvKvKJsZacaPDaxFRxwkhD5Ct0QImks7pu-d6Leh8dp3RJymGskrV8g_aZqERLJD9AN-sLg5fjBnTGYcDg8dJr2xufweGzkAwOHs-vrXMQt3g9jSHiRfA5BlfgHq_DtdU2b7H1eBU0OPvX9Pg0GkgZL-4b_Izn-KcpirQxOtsrg-ce3DbZ9Ba9HsAlc_z4HqFf376uF-ez1Y_vy8V8NdOcVnkmeuj6oalNbVqua0kH6CWwQXAqxQDlCuhYR2jNGimZ1JT0XJNWU9EB74AdoS8PvpupG02vy3QRnNpEO5apVACr_v3x9kL9DleqaRjnghWDj48GMfyZTMpqtEmbshRvwpQUrWlLatpwWdAPO-hlmGIZ-J6SgvKmIYV6_7Kj51aeginAyQOgy95SNMMzUhF1l77aSb8oxI6i5ALZ3oUF1v1XdwvIC7bR
CitedBy_id crossref_primary_10_3389_fonc_2025_1598730
crossref_primary_10_3390_jpm12040653
crossref_primary_10_1097_COC_0000000000001018
Cites_doi 10.1245/s10434-014-3966-1
10.1016/j.ijrobp.2018.03.046
10.1016/j.ijrobp.2005.12.044
10.1016/j.radonc.2014.11.030
10.3857/roj.2017.00381
10.1007/s10549-005-9025-7
10.1001/jama.2017.11470
10.1016/j.canrad.2021.06.002
10.1056/NEJMoa022152
10.1007/s00066-021-01808-y
10.1016/j.ijrobp.2004.04.065
10.1002/jso.21535
10.1097/MD.0000000000004036
10.1016/j.compmedimag.2016.10.001
10.1200/JCO.2013.49.7842
10.1016/j.ijrobp.2008.02.080
10.1002/bjs.7360
10.1016/j.ijrobp.2008.10.034
10.1016/j.radonc.2019.08.021
10.1016/j.radonc.2009.07.005
10.1016/j.ijrobp.2013.11.232
10.1016/j.ejso.2015.05.007
10.1067/j.cpsurg.2016.11.003
10.1259/bjr/25788274
10.1016/S0360-3016(99)00132-7
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID AAYXX
CITATION
NPM
3V.
7T5
7TO
7XB
8FE
8FH
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
GUQSH
H94
HCIFZ
LK8
M2O
M7P
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.3390/cancers14030807
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Biological Science Collection
Research Library
Biological Science Database
Research Library (Corporate)
Proquest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2072-6694
ExternalDocumentID PMC8834453
35159074
10_3390_cancers14030807
Genre Journal Article
GeographicLocations France
GeographicLocations_xml – name: France
GroupedDBID ---
53G
5VS
8FE
8FH
8G5
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACUHS
ADBBV
AFFHD
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
ESX
GNUQQ
GUQSH
GX1
HCIFZ
HYE
IAO
IHR
ITC
KQ8
LK8
M2O
M48
M7P
MODMG
M~E
OK1
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PQGLB
PQQKQ
PROAC
RPM
TUS
NPM
3V.
7T5
7TO
7XB
8FK
H94
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c421t-5dabdf86e6e94c672fad7a3f54275fafaf5ab3b026387737c20d4c09c25ba4ba3
IEDL.DBID M7P
ISICitedReferencesCount 4
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000760315600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2072-6694
IngestDate Tue Nov 04 02:05:33 EST 2025
Sun Nov 09 05:15:18 EST 2025
Fri Jul 25 10:34:30 EDT 2025
Thu Apr 03 06:56:50 EDT 2025
Sat Nov 29 07:12:22 EST 2025
Tue Nov 18 22:15:35 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords axillary lymph node
dosimetric analysis
radiotherapy
intensity-modulated radiotherapy
three-dimensional radiotherapy
breast carcinoma
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c421t-5dabdf86e6e94c672fad7a3f54275fafaf5ab3b026387737c20d4c09c25ba4ba3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-4952-5572
0000-0002-3969-6610
0000-0002-8102-771X
OpenAccessLink https://www.proquest.com/docview/2627524880?pq-origsite=%requestingapplication%
PMID 35159074
PQID 2627524880
PQPubID 2032421
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8834453
proquest_miscellaneous_2629062847
proquest_journals_2627524880
pubmed_primary_35159074
crossref_primary_10_3390_cancers14030807
crossref_citationtrail_10_3390_cancers14030807
PublicationCentury 2000
PublicationDate 20220204
PublicationDateYYYYMMDD 2022-02-04
PublicationDate_xml – month: 2
  year: 2022
  text: 20220204
  day: 4
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Cancers
PublicationTitleAlternate Cancers (Basel)
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Warren (ref_8) 2014; 88
Gonzalez (ref_10) 2006; 65
Teerenstra (ref_27) 2011; 98
Hong (ref_7) 1999; 44
Li (ref_3) 2015; 41
Rastogi (ref_5) 2018; 36
Ercan (ref_24) 2010; 83
ref_19
Lee (ref_23) 2016; 95
Donker (ref_2) 2015; 159
ref_17
ref_15
Offersen (ref_18) 2015; 114
Fleissig (ref_26) 2006; 95
Fisher (ref_28) 2002; 347
Hayes (ref_14) 2008; 72
Gross (ref_13) 2018; 102
Belkacemi (ref_22) 2014; 21
Dominici (ref_1) 2016; 53
Reynders (ref_11) 2009; 93
Mukesh (ref_9) 2013; 31
Reznik (ref_21) 2005; 61
Ashikaga (ref_12) 2010; 102
Li (ref_25) 2009; 73
Schmitt (ref_16) 2021; 197
Liu (ref_6) 2016; 54
Borm (ref_20) 2020; 142
Giuliano (ref_4) 2017; 318
References_xml – volume: 21
  start-page: 3758
  year: 2014
  ident: ref_22
  article-title: Breast Radiotherapy (RT) Using Tangential Fields (TgF): A Prospective Evaluation of the Dose Distribution in the Sentinel Lymph Node (SLN) Area as Determined Intraoperatively by Clip Placement
  publication-title: Ann. Surg. Oncol.
  doi: 10.1245/s10434-014-3966-1
– volume: 102
  start-page: 71
  year: 2018
  ident: ref_13
  article-title: Radiation Therapy Field Design and Lymphedema Risk after Regional Nodal Irradiation for Breast Cancer
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2018.03.046
– volume: 65
  start-page: 284
  year: 2006
  ident: ref_10
  article-title: Evaluation of Two Tomotherapy-Based Techniques for the Delivery of Whole-Breast Intensity-Modulated Radiation Therapy
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2005.12.044
– volume: 114
  start-page: 3
  year: 2015
  ident: ref_18
  article-title: ESTRO Consensus Guideline on Target Volume Delineation for Elective Radiation Therapy of Early Stage Breast Cancer
  publication-title: Radiother. Oncol.
  doi: 10.1016/j.radonc.2014.11.030
– volume: 36
  start-page: 71
  year: 2018
  ident: ref_5
  article-title: Dosimetric Comparison of IMRT versus 3DCRT for Post-Mastectomy Chest Wall Irradiation
  publication-title: Radiat. Oncol. J.
  doi: 10.3857/roj.2017.00381
– volume: 95
  start-page: 279
  year: 2006
  ident: ref_26
  article-title: Post-Operative Arm Morbidity and Quality of Life. Results of the ALMANAC Randomised Trial Comparing Sentinel Node Biopsy with Standard Axillary Treatment in the Management of Patients with Early Breast Cancer
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-005-9025-7
– volume: 318
  start-page: 918
  year: 2017
  ident: ref_4
  article-title: Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival among Women with Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial
  publication-title: JAMA
  doi: 10.1001/jama.2017.11470
– ident: ref_15
  doi: 10.1016/j.canrad.2021.06.002
– volume: 347
  start-page: 1233
  year: 2002
  ident: ref_28
  article-title: Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa022152
– volume: 197
  start-page: 820
  year: 2021
  ident: ref_16
  article-title: Incidental Axillary Dose Delivery to Axillary Lymph Node Levels I-III by Different Techniques of Whole-Breast Irradiation: A Systematic Literature Review
  publication-title: Strahlenther. Onkol.
  doi: 10.1007/s00066-021-01808-y
– volume: 159
  start-page: A9302
  year: 2015
  ident: ref_2
  article-title: Axillary lymph node dissection versus axillary radiotherapy in patients with a positive sentinel node: The AMAROS trial
  publication-title: Ned. Tijdschr. Geneeskd.
– volume: 61
  start-page: 163
  year: 2005
  ident: ref_21
  article-title: Analysis of Axillary Coverage during Tangential Radiation Therapy to the Breast
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2004.04.065
– volume: 102
  start-page: 111
  year: 2010
  ident: ref_12
  article-title: Morbidity Results from the NSABP B-32 Trial Comparing Sentinel Lymph Node Dissection versus Axillary Dissection
  publication-title: J. Surg. Oncol.
  doi: 10.1002/jso.21535
– volume: 95
  start-page: e4036
  year: 2016
  ident: ref_23
  article-title: Dosimetric Evaluation of Incidental Irradiation to the Axilla during Whole Breast Radiotherapy for Patients with Left-Sided Early Breast Cancer in the IMRT Era
  publication-title: Medicine
  doi: 10.1097/MD.0000000000004036
– volume: 54
  start-page: 1
  year: 2016
  ident: ref_6
  article-title: Evaluation of 3D-CRT, IMRT and VMAT Radiotherapy Plans for Left Breast Cancer Based on Clinical Dosimetric Study
  publication-title: Comput. Med. Imaging Graph.
  doi: 10.1016/j.compmedimag.2016.10.001
– volume: 31
  start-page: 4488
  year: 2013
  ident: ref_9
  article-title: Randomized Controlled Trial of Intensity-Modulated Radiotherapy for Early Breast Cancer: 5-Year Results Confirm Superior Overall Cosmesis
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2013.49.7842
– volume: 72
  start-page: 1449
  year: 2008
  ident: ref_14
  article-title: Does Axillary Boost Increase Lymphedema Compared with Supraclavicular Radiation Alone after Breast Conservation?
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2008.02.080
– volume: 98
  start-page: 326
  year: 2011
  ident: ref_27
  article-title: Systematic Review of the Effect of External Beam Radiation Therapy to the Breast on Axillary Recurrence after Negative Sentinel Lymph Node Biopsy
  publication-title: Br. J. Surg.
  doi: 10.1002/bjs.7360
– volume: 73
  start-page: 944
  year: 2009
  ident: ref_25
  article-title: Variability of Target and Normal Structure Delineation for Breast Cancer Radiotherapy: An RTOG Multi-Institutional and Multiobserver Study
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2008.10.034
– volume: 142
  start-page: 195
  year: 2020
  ident: ref_20
  article-title: Irradiation of Regional Lymph Node Areas in Breast Cancer—Dose Evaluation According to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 Field Design
  publication-title: Radiother. Oncol.
  doi: 10.1016/j.radonc.2019.08.021
– volume: 93
  start-page: 71
  year: 2009
  ident: ref_11
  article-title: Dosimetric Assessment of Static and Helical TomoTherapy in the Clinical Implementation of Breast Cancer Treatments
  publication-title: Radiother. Oncol.
  doi: 10.1016/j.radonc.2009.07.005
– volume: 88
  start-page: 565
  year: 2014
  ident: ref_8
  article-title: The Impact of Radiation Therapy on the Risk of Lymphedema after Treatment for Breast Cancer: A Prospective Cohort Study
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2013.11.232
– ident: ref_17
– ident: ref_19
– volume: 41
  start-page: 958
  year: 2015
  ident: ref_3
  article-title: Axillary Lymph Node Dissection versus Sentinel Lymph Node Biopsy Alone for Early Breast Cancer with Sentinel Node Metastasis: A Meta-Analysis
  publication-title: Eur. J. Surg. Oncol.
  doi: 10.1016/j.ejso.2015.05.007
– volume: 53
  start-page: 559
  year: 2016
  ident: ref_1
  article-title: Trends and Controversies in Multi-Disciplinary Care of the Breast Cancer Patient
  publication-title: Curr. Probl. Surg.
  doi: 10.1067/j.cpsurg.2016.11.003
– volume: 83
  start-page: 1072
  year: 2010
  ident: ref_24
  article-title: Coverage of Axillary Lymph Nodes with High Tangential Fields in Breast Radiotherapy
  publication-title: Br. J. Radiol.
  doi: 10.1259/bjr/25788274
– volume: 44
  start-page: 1155
  year: 1999
  ident: ref_7
  article-title: Intensity-Modulated Tangential Beam Irradiation of the Intact Breast
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/S0360-3016(99)00132-7
SSID ssj0000331767
Score 2.2788196
Snippet Purpose: The dosimetric analysis of the incidental axillary dose delivered to axillary lymph node levels I–III by different techniques of whole breast...
The dosimetric analysis of the incidental axillary dose delivered to axillary lymph node levels I-III by different techniques of whole breast irradiation and...
Simple SummaryThe incidental axillary dose varies according to the whole breast irradiation technique. However, this dose has not been shown to be a prognostic...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 807
SubjectTerms Body mass index
Breast cancer
Breast carcinoma
Cancer therapies
Dosimetry
Fractions
Lumpectomy
Lymph nodes
Lymphatic system
Lymphedema
Mastectomy
Metastasis
Patients
Radiation therapy
Risk factors
Software
Statistical analysis
Toxicity
Tumors
Title The Impact of an Incidental Dose on Axillary Tumor Control and Toxicity in Localized Breast Cancer: A Retrospective Analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/35159074
https://www.proquest.com/docview/2627524880
https://www.proquest.com/docview/2629062847
https://pubmed.ncbi.nlm.nih.gov/PMC8834453
Volume 14
WOSCitedRecordID wos000760315600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2072-6694
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000331767
  issn: 2072-6694
  databaseCode: M~E
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2072-6694
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000331767
  issn: 2072-6694
  databaseCode: M7P
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2072-6694
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000331767
  issn: 2072-6694
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Research Library (NC LIVE)
  customDbUrl:
  eissn: 2072-6694
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000331767
  issn: 2072-6694
  databaseCode: M2O
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2072-6694
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000331767
  issn: 2072-6694
  databaseCode: PIMPY
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-xDSFe-B4ERmUkHngJS-0kTnhBXdnEJFqiqUjlqbIdR1SCZCQp2hB_PHf5gg7BC8pT4nPi-O58Z_v8O4DnRhmhpNZunPHQRYsXulqkHmp8qlKpo3FosybZhJzPo-UyTroFt6oLq-zHxGagTgtDa-SHnOB0OYnb6_OvLmWNot3VLoXGDuwRSoJoQveSYY3FE2gdQ9ki-gic3R8a6sqyIpA6dJXktjH6w8O8Gij5m-U5uf2_bb4Dtzqfk01aIbkL12x-D27Mul31-_ADZYWdNsclWZExlTMcNSjZKDrm7E1RWVbkbHJB-YnKS7bYfClKNm1D3JE4ZYviAt9UX7J1zt6RbVx_tyk7onD3mk2bvnjFJuzMYo3-ZCfr0VAewIeT48X0rdtlZXCNz8e1G6RKp1kU2tDGvgklz5CpSmSBjz-bKbwCpYXGuZ2IpBTScC_1jRcbHmjlayX2YTcvcvsIGPoWGXoUQZDp1Pd0rLyxCXD-hsITq4j7Drzs2bMyHWQ5Zc74vMKpC_FzdYWfDrwYKpy3aB1_Jz3oebbq1LZa_WKYA8-GYlQ42kVRuS02DQ1hO6NVd-BhKx7DtwR5h-iUOSC3BGcgIDDv7ZJ8_akB9Y4o4UkgHv-7WU_gJqfzFxQ27h_Abl1u7FO4br7V66ocwY5cRiPYOzqeJ2d4N-PvR41G4LPkdJZ8_An9iRfm
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VgoAL74ehwCKBxMXU2bW9NhJCIaVq1DSqUJB6M7vrtYgEdrEdaBC_id_IjB0bUgS3HpCPXr-_mflmPfsNwBOjjFBSazfOeOhixAtdLVIPLT5VqdTRILRZ02xCTqfR0VF8uAE_urUwVFbZ-cTGUaeFoTnybU5yupzg9ur4s0tdo-jvatdCo4XFvl1-xZStejnewe_7lPPdN7PRnrvqKuAanw9qN0iVTrMotKGNfRNKnuFNKZEFPl4gU7gFSguNuYmIpBTScC_1jRcbHmjlayXwvOfgPNIIHjWlgof9nI4nMBqHslUQEiL2tg19urIiUTykZnI9-P3BaE8XZv4W6Xav_m_v6BpcWXFqNmyN4Dps2PwGXDxYVQ3chO9oC2zcLAdlRcZUztArUjNVTDzYTlFZVuRseEL9l8olmy0-FSUbtSX8ODhls-IEz1Qv2TxnE4r98282Za-pnL9mo-bdv2BD9tbiEd3KVdapvdyCd2fy7LdhMy9yexcYcqcMGVMQZDr1PR0rb2ACzE_ROGIVcd-B5x0cErOSZKfOIB8TTM0IP8kp_DjwrD_guFUj-fvQrQ4jycotVckvgDjwuN-NDoX-EqncFotmDGlXI2tx4E4Lx_5agtgvkk4H5BpQ-wEkVr6-J59_aETLI2roEoh7_76tR3Bpb3YwSSbj6f59uMxprQmVyPtbsFmXC_sALpgv9bwqHzaWx-D9WcP4J5aVchI
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lj9MwEB4tC1px4f0ILGAkkLiEpnYSJ0gIlZaKapeqQkXaW7AdR1SCZGlS2CJ-Gb-OmTwKXQS3PaAc49hJ_M34m2T8DcAjo4xQUms3znjo4ooXulqkHlp8qlKpo35os7rYhJxOo6OjeLYDP7q9MJRW2fnE2lGnhaFv5D1Ocrqc4NbL2rSI2Wj84vizSxWk6E9rV06jgciBXX_F8K18PhnhXD_mfPxqPnztthUGXOPzfuUGqdJpFoU2tLFvQskzvEElssDHwTKFR6C00BiniEhKIQ33Ut94seGBVr5WAvs9B-cliZbXaYOzzfcdT-DKHMpGTUiI2OsZmsZlSQJ5SNPk9kL4B7s9naT526o3vvw_v68rcKnl2mzQGMdV2LH5Ndh702YTXIfvaCNsUm8TZUXGVM7QW1KRVQxI2KgoLStyNjihukzLNZuvPhVLNmxS-7FxyubFCfZUrdkiZ4fECRbfbMpeUpp_xYb1PDxjA_bW4hXdjlbWqcDcgHdn8uw3YTcvcnsbGHKqDJlUEGQ69T0dK69vAoxb0WhiFXHfgacdNBLTSrVTxZCPCYZshKXkFJYceLK54LhRKfl70_0OL0nrrsrkF1gceLg5jY6G_h6p3Barug1pWiObceBWA83NWIJYMZJRB-QWaDcNSMR8-0y--FCLmUdU6CUQd_59Ww9gD9GbHE6mB3fhIqctKJQ57-_DbrVc2XtwwXypFuXyfm2EDN6fNYp_Ai3tes8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Impact+of+an+Incidental+Dose+on+Axillary+Tumor+Control+and+Toxicity+in+Localized+Breast+Cancer%3A+A+Retrospective+Analysis&rft.jtitle=Cancers&rft.au=Schmitt%2C+Martin&rft.au=Chambrelant%2C+Isabelle&rft.au=Hong+Chheang%2C+Parigna&rft.au=Pflumio%2C+Carole&rft.date=2022-02-04&rft.issn=2072-6694&rft.eissn=2072-6694&rft.volume=14&rft.issue=3&rft_id=info:doi/10.3390%2Fcancers14030807&rft_id=info%3Apmid%2F35159074&rft.externalDocID=35159074
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6694&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6694&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6694&client=summon